Rhythm Biosciences Ltd has released a press release.
Investor Presentation
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
In the deck
Story so far
Earlier from Rhythm Biosciences
- UK Strategic Partnership with LINK Medical Solutions
- UK CA Mark granted for ColoSTAT
- Executive Management Change
- ColoSTAT abstracts accepted at 2023 ASCO Annual Meeting
- Reinstatement to Official Quotation
Later from Rhythm Biosciences
- RHY 2023 AGM Presentation
- Response to ASX Query
- Receipt of First Tranche of $1.69m in R&D Tax Incentive
- Executive Management Changes
- Platform Expansion - Lung Cancer Diagnostic Test Update
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences